We have been collaborating with our partners in the PERSIST-SEQ consortium to uncover how tumors resist treatment by standardizing scalable single-cell sequencing and identifying new approaches to overcome drug resistance.
In the fourth episode of PERSIST-SEQ’s behind-the-scenes video series, our very own Dylan Mooijman, Mauro Muraro, and Oriol Llorà Batlle pull back the curtain on how SCD is contributing to the consortium. This series is a behind-the-scenes look at the collaborative science shaping the future of cancer treatment.
From standardizing workflows across dozens of labs to integrating the latest spatial transcriptomics methods, our team helps PERSIST-SEQ generate, process, and share data. With over 2 million cells already sequenced (and 5 million in sight), this dataset is poised to push the field forward.
Watch the full episode on Lygature’s YouTube channel here.